Hiroshi Tsubamoto
- Molecular Biology
- Reproductive Medicine top 2%
- Oncology
- Public Health, Environmental and Occupational Health top 10%
- Obstetrics and Gynecology top 5%
- Co-authors
- Kayo InoueTakashi SonodaHiroaki ShibaharaKazuko SakataKoji KoyamaTomoko UedaAkiko HasegawaShinichi Ikuta
- Topics
- Endometrial and Cervical Cancer Treatments (27 papers)Ovarian cancer diagnosis and treatment (26 papers)Uterine Myomas and Treatments (11 papers)
- Journals
- Journal of Clinical OncologyCancer ResearchBiochemical and Biophysical Research Communications
- Partner nations
- JapanUnited States
In The Last Decade
Hiroshi Tsubamoto
91 papers receiving 894 citations
Peers
Comparison fields: 5 of 87
- Molecular Biology 368
- Reproductive Medicine 253
- Oncology 211
- Public Health, Environmental and Occupational Health 205
- Obstetrics and Gynecology 154
Countries citing papers authored by Hiroshi Tsubamoto
This map shows the geographic impact of Hiroshi Tsubamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Tsubamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Tsubamoto more than expected).
Fields of papers citing papers by Hiroshi Tsubamoto
This network shows the impact of papers produced by Hiroshi Tsubamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Tsubamoto. The network helps show where Hiroshi Tsubamoto may publish in the future.
Co-authorship network of co-authors of Hiroshi Tsubamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Tsubamoto. A scholar is included among the top collaborators of Hiroshi Tsubamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Tsubamoto. Hiroshi Tsubamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 8 | |
| 3 | 6 | |
| 4 | 2 | |
| 5 | 16 | |
| 6 | 12 | |
| 7 | 5 | |
| 8 | 5 | |
| 9 | 33 | |
| 10 | 3 | |
| 11 | 64 | |
| 12 | Combination Chemotherapy with Itraconazole for Treating Metastatic Pancreatic Cancer in the Second-line or Additional Setting. | 43 |
| 13 | Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancer. | 36 |
| 14 | 1 | |
| 15 | 8 | |
| 16 | 8 | |
| 17 | 8 | |
| 18 | 12 | |
| 19 | 51 | |
| 20 | 4 |
About Hiroshi Tsubamoto
Hiroshi Tsubamoto is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 95 papers that have together received 921 indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (27 papers), Ovarian cancer diagnosis and treatment (26 papers) and Uterine Myomas and Treatments (11 papers). The work is most often cited by research in Reproductive Medicine (253 citations), Obstetrics and Gynecology (154 citations) and Oncology (211 citations). Hiroshi Tsubamoto has collaborated with scholars based in Japan and United States. Frequent co-authors include Kayo Inoue, Takashi Sonoda, Hiroaki Shibahara, Kazuko Sakata, Koji Koyama, Tomoko Ueda, Akiko Hasegawa, Shinichi Ikuta, Naoki Yamanaka and Satoshi Tani. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.